Association of glucagon‐like peptide‐1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy - Kobori, Toshiko; Onishi, Yukiko; Yoshida, Yoko; Tahara, Tazu; Kikuchi, Takako; Kubota, Tetsuya; Iwamoto, Masahiko; Sawada, Tomonobu; Kobayashi, Reo; Fujiwara, Hiroaki; Kasuga, Masato (Journal of diabetes investigation, 2023)
Keywords: Agonists; Case-Control Studies; Cohort analysis; Diabetes; Diabetes mellitus; Diabetes Mellitus, Type 2 - drug therapy; Diabetic retinopathy; Esophagogastroduodenoscopy; Fasting; Gastric emptying; Gastric residue; GLP-1 receptor agonists; Glucagon; Glucagon-like peptide 1; Glucagon-Like Peptide-1 Receptor - agonists; Glucagon‐like peptide‐1 receptor agonist treatment; Glucose; Hemoglobin; Humans; Hypoglycemic Agents - therapeutic use; Insulin; Liraglutide - therapeutic use; Original; Paracetamol; Patients; Peptides; Population studies; Glucagon-like peptide-1 receptor agonist treatment; Esophagogastroduodenoscopy; Gastric residue